Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > VRX CEO hit with "severe" pneumonia.
View:
Post by Stockcoach1 on Dec 28, 2015 1:15am

VRX CEO hit with "severe" pneumonia.

read more at 

https://seekingalpha.com/article/3777006-valeant-ceos-severe-pneumonia-underscores-key-man-risk
Comment by Stockcoach1 on Dec 28, 2015 12:26pm
Valeant CEO Takes Temporary Leave on Health Scare by CHRIS LANGE | DEC. 28, 2015 Valeant Pharmaceuticals International Inc. (NYSE: VRX) watched its shares move lower in Monday’s trading session on a health scare from one of its top executives. Chief Executive Officer J. Michael Pearson, was hospitalized over the Christmas holiday with a severe case of pneumonia.   In response to this ...more  
Comment by dusoft24x7 on Dec 28, 2015 9:04pm
Back to basics on corporate communications. There is going to another followup communication now that market does not like this intermin CEO office concept.
Comment by EStreet on Dec 28, 2015 11:01pm
Don't get it,,,last month this guy was such a liability that everyone wanted to axe the guy now he takes time off for a legitimate illness and the share price goes into a free fall,,,!!!!
Comment by jtcommon on Dec 29, 2015 9:02am
Hope that Mr. Pearson will have a speedy recovery. The appointment of a trio to fill in for Mr. Pearson highlights at least another concern for me regarding the company -- Valeant does not have a succession plan. Of courses, this is bad news among many headwinds Valeant is facing.  But if the SP tests Novemeber low in the near future, the stock might just be worth a look. -JT
Comment by biggerr on Dec 29, 2015 8:13pm
rockin' pneumonia and the boogie woogie flu
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities